FDA Inspection 1021881 — Peter Charles Klatsky, M.D., Inc.
The FDA completed an inspection of Peter Charles Klatsky, M.D., Inc. on July 31, 2017 in San Francisco, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 31, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- San Francisco, CA (United States)